Search

everythinglearnresearchcommunity

for

Search:↓

Photodynamic therapy was effective in treating multiple scalp basal cell carcinomas with minimal side effects and good cosmetic results.

Basal cell carcinoma mostly starts from cells in the upper skin layers, not hair follicle stem cells.

YAP and TAZ proteins are necessary for the development of two types of skin cancer.

Basal cell carcinomas have much higher levels of Vitamin D3 receptors compared to healthy skin.

Most people with basal cell carcinoma on their head or neck were 60-70 years old, and it often came back even after being fully removed, especially in certain areas and types.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

The research created a detailed map of skin cells, showing that certain cells in basal cell carcinoma may come from hair follicles and could help the cancer grow.

The antibody created from BCC tissues reacts similarly to both BCC and hair follicles, suggesting BCC may come from hair follicle cells.

Higher levels of nidogen1 and type IV collagen are found in basal cell carcinoma compared to normal skin.

Intralesional chemotherapy with 5-fluorouracil and methotrexate may worsen keratoacanthoma-type skin cancer in transplant patients.

GLI1 might protect against the start of skin cancer and is not linked to cancer severity.

A man with myotonic dystrophy type 1 had 28 skin cancers, suggesting a link between the disease and skin cancer, emphasizing the need for sun protection and regular skin checks.

A rare type of skin cancer on the scalp can be mistaken for hair loss, causing delayed diagnosis and severe damage.

Skin cancer in sun-exposed areas is more likely to come back.

A man with a rare scalp cancer was successfully treated, highlighting the need for early management to prevent spread and complications.

CK 15, follistatin, and Bmi-1 can help differentiate basal cell carcinoma from squamous cell carcinoma.

Understanding and managing side effects of hedgehog pathway inhibitors can improve treatment for advanced basal cell carcinoma.

A small group of slow-growing cells causes basal cell carcinoma to return after treatment.

Activating Notch signaling can kill basal cell carcinoma cells.

External factors can cause skin cancer cells that usually don't spread to grow and form tumors in mice.

Targeting ornithine decarboxylase can help prevent skin cancer.

Inhibiting ornithine decarboxylase may help prevent certain skin cancers.

Skin problems are common in Bangladesh due to arsenic, prompt treatment of diabetic foot ulcers is crucial, maternal transmission causes most neonatal herpes, treatments for pediatric vasculitis are effective, the chickenpox vaccine works, more frequent UVB therapy helps psoriasis, certain jobs increase hand dermatitis risk, monoclonal antibodies treat psoriasis well, lifestyle affects psoriasis, alefacept improves psoriasis, imiquimod cream partially clears basal cell carcinoma, and iron may not help chronic hair loss.

Nonmelanoma skin cancers have higher levels of certain osteopontin variants than normal skin.

A woman with a new PTCH gene mutation has both Gorlin syndrome and severe hair loss.

Obesity increases the risk of skin infections, inflammatory conditions, and melanoma, but not basal cell carcinoma.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Mohs micrographic surgery is effective for treating basal cell carcinoma on the eyelid, while radiotherapy has higher recurrence rates, and topical vitamin D3 may reduce and delay BCC formation in mice.

LDE225 is a promising skin-applied treatment for basal cell carcinoma with good skin penetration and effectiveness.

Older adults have a high rate of skin cancers like basal cell carcinoma and melanoma, mainly due to UV exposure and age.